El mercado farmacéutico de patente expirada tiene un comportamiento interesante respecto a su estructura mercado, cambiando de una estructura monopólica derivada de la protección de patente a un oligopolio, donde la empresa que tenía dicha protección (pionera) ostenta el rol de dominante mediante en un juego a la Stackelberg, la cual aplica estrategias de diferenciación de producto en un mercado segmentado, el cual es poco sensible a los precios y que conserva una cuota no despreciable. En este sentido, otras empresas que fabrican genéricos con una marca comercial, penetran el mercado con una estrategia similar a la dominante, aunque con precios menores. Esto se debe al prestigio y posicionamiento competitivo del producto con reciente expiración. Consecuentemente, se ofertan productos poco diferenciados que compiten por precios económicos, los cuales obtienen una penetra...

The expired patent pharmaceutical market has an interesting behavior with respect to its market structure, changing from a monopolistic case derived from patent protection to an oligopoly, where the company that had such protection (pioneer) holds the dominant role through a Stackelberg behavior, which applies strategies of product differentiation in a segmented market, which is not very sensitive to change in prices and which retains a non-negligible share. In this sense, other companies that manufacture generics with a commercial brand, penetrate the market with a similar strategy with differentiated products and lower prices. This is due to the prestige and competitive positioning of the product with recent expiration. Consequently, little differentiated products are offered that compete for economic prices, which obtain a considerable market penetration in a price-sensitive se...

The expired patent pharmaceutical market has an interesting behavior with respect to its market structure, changing from a monopolistic case derived from patent protection to an oligopoly, where the company that had such protection (pioneer) holds the dominant role through a Stackelberg behavior, which applies strategies of product differentiation in a segmented market, which is not very sensitive to change in prices and which retains a non-negligible share. In this sense, other companies that manufacture generics with a commercial brand, penetrate the market with a similar strategy with differentiated products and lower prices. This is due to the prestige and competitive positioning of the product with recent expiration. Consequently, little differentiated products are offered that compete for economic prices, which obtain a considerable market penetration in a price-sensitive se...